Ammonia → 3-{5-[4-Methyl-5-(4-sulfamoyl-phenyl)-thiazol-2-ylamino]-[1,3,4]thiadiazol-2-yl}-propionic acid
反応式
[NH:1]([C:5]1[S:9][C:8]([CH2:10][CH2:11][C:12]([OH:14])=[O:13])=[N:7][N:6]=1)[C:2]([NH2:4])=[S:3].O=[C:16]([CH3:28])[CH2:17][C:18]1[CH:23]=[CH:22][C:21]([S:24]([NH2:27])(=[O:26])=[O:25])=[CH:20][CH:19]=1.N>>[CH3:28][C:16]1[N:4]=[C:2]([NH:1][C:5]2[S:9][C:8]([CH2:10][CH2:11][C:12]([OH:14])=[O:13])=[N:7][N:6]=2)[S:3][C:17]=1[C:18]1[CH:19]=[CH:20][C:21]([S:24](=[O:26])(=[O:25])[NH2:27])=[CH:22][CH:23]=1参加物
4
実験手順
The titled compound is prepared from 3-(5-thioureido-[1,3,4]thiadiazol-2-yl)-propionic acid (56b) and from 4-(2-oxo-propyl)-benzenesulfonyl chloride (prepared as described in European patent specification EP 91749 A2) following procedures described for Example 1 using ammonia to prepare the sulfonamide.
出典と根拠
- ORDレコード
- ord-4788d986175a43fe8f863eaa41a79975
- 出典データセット
- uspto-grants-2011_09
- 特許番号
- US08017608B2
反応ノート
読み込み中…